Etop Ibcsg Partners Foundation

This study tested a treatment plan for people with non-small cell lung cancer that has spread to a small number of other body sites (up to 3). The approach combines immunotherapy and chemotherapy with precise radiation to the cancer spots, followed by surgery or radiation to the …

This study looks at whether young women with early-stage, hormone-sensitive breast cancer can safely pause their hormone therapy for up to two years to try to get pregnant. It involves 518 women aged 18 to 42 who have already been on hormone therapy for at least 18 months. The go…

This study tests whether adding the drug palbociclib to standard hormone therapy can keep breast cancer from coming back in people whose cancer has returned in the same area. About 405 participants will receive either the combination or hormone therapy alone for 3 years. The goal…

This study tests a daily pill called adagrasib in 68 patients with a specific type of advanced lung cancer (KRAS G12C mutation) who are either 70 or older or have poor physical health. The goal is to see if the drug can shrink tumors or stop them from growing. Patients take the m…

This study tests a combination of three drugs (amivantamab, lazertinib, and bevacizumab) in 60 people with advanced EGFR-mutant non-small cell lung cancer whose disease worsened after previous treatment. The goal is to see if adding two drugs to a standard targeted therapy can sh…